Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
InMed Pharmaceuticals Inc. (INM) had Income from Continuous Operations of $-2.12M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$1.26M |
|
$-2.12M |
|
$1.09M |
|
$0.18M |
|
$3.38M |
|
$-2.12M |
|
$-0.01M |
|
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
|
Income from Continuous Operations |
$-2.12M |
$-2.12M |
|
$-2.12M |
|
$-2.12M |
|
$-2.06M |
|
1.10M |
|
1.10M |
|
$-1.94 |
|
$-1.94 |
|
| Balance Sheet Financials | |
$6.41M |
|
$1.11M |
|
$2.87M |
|
$9.28M |
|
$1.84M |
|
$0.42M |
|
$0.42M |
|
$2.26M |
|
$7.02M |
|
$5.36M |
|
$7.02M |
|
1.21M |
|
| Cash Flow Statement Financials | |
$-5.99M |
|
$0.00M |
|
$4.10M |
|
$6.57M |
|
$4.68M |
|
$-1.89M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.49 |
|
-- |
|
-- |
|
0.06 |
|
0.12 |
|
13.92% |
|
-167.67% |
|
-167.67% |
|
-- |
|
-168.12% |
|
-168.12% |
|
$-5.99M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.33 |
|
3.43 |
|
26.24 |
|
-30.21% |
|
-39.57% |
|
-22.86% |
|
-28.50% |
|
$5.82 |
|
$-5.46 |
|
$-5.46 |
|